Cargando…

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Detalles Bibliográficos
Autores principales:	Talaei, M., Robertson, N. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739524/ https://www.ncbi.nlm.nih.gov/pubmed/34878608 http://dx.doi.org/10.1007/s00415-021-10908-9

Ejemplares similares

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Neurological complications of COVID-19: a preliminary review
por: Pryce-Roberts, A., et al.
Publicado: (2020)

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
por: Mahdi-Rogers, Mohamed, et al.
Publicado: (2010)

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2
por: Cauchi, M., et al.
Publicado: (2021)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Neurotoxicity of novel cancer immunotherapies
por: Willis, M. D., et al.
Publicado: (2019)

Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis
por: Willis, M. D., et al.
Publicado: (2017)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
por: Willis, M. D., et al.
Publicado: (2020)

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions
por: Bari, S., et al.
Publicado: (2023)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment
por: Hrastelj, J., et al.
Publicado: (2021)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

Why antisense could make sense for neurodegeneration
por: Massey, T. H., et al.
Publicado: (2017)

Zika virus and neurology: proving cause and effect
por: Massey, T. H., et al.
Publicado: (2016)

Restless legs syndrome: causes and consequences
por: Massey, T. H., et al.
Publicado: (2020)

Socioeconomic status in neurological disorders: a modifiable risk factor?
por: Hrastelj, J., et al.
Publicado: (2022)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Clinical patterns in CADASIL
por: Gailani, G., et al.
Publicado: (2022)

Autoimmune encephalitis: clinical presentation, investigation and treatment
por: Al-Ansari, A., et al.
Publicado: (2021)

Postural orthostatic tachycardia syndrome: insights into pathogenesis and treatment
por: Al-Ansari, A., et al.
Publicado: (2021)

Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

Anti-epileptics and pregnancy: an update
por: Al-Ansari, A., et al.
Publicado: (2018)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms
por: Peall, K. J., et al.
Publicado: (2017)

Reversing the trend: interventions to treat intracranial haemorrhage associated with anticoagulation
por: McLauchlan, D., et al.
Publicado: (2016)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
por: Al-Ansari, Aseel, et al.
Publicado: (2017)

Autoimmune encephalitis: frequency and prognosis
por: Al-Ansari, A., et al.
Publicado: (2019)

Cerebral venous thrombosis: clinical predictors and emerging treatments
por: Al-Ansari, A., et al.
Publicado: (2020)

Cluster headache: an overview of established and emerging treatments
por: Al-Ansari, A., et al.
Publicado: (2019)

Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis
por: McLauchlan, D., et al.
Publicado: (2020)

Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)

Cerebral amyloid angiopathy: an update
por: Schroeder, B. E., et al.
Publicado: (2023)

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment
por: McLauchlan, D., et al.
Publicado: (2017)

Advances in Tourette’s syndrome
por: Robertson, Neil P.
Publicado: (2023)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia
por: Saw, Aung M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0mfe8id5mnids06ao717t9kvf4